Is radiomic MRI a feasible alternative to OncotypeDX(®) recurrence score testing? A systematic review and meta-analysis

BACKGROUND: OncotypeDX(®) recurrence score (RS) aids therapeutic decision-making in oestrogen-receptor-positive (ER+) breast cancer. Radiomics is an evolving field that aims to examine the relationship between radiological features and the underlying genomic landscape of disease processes. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales: Davey, M G, Davey, M S, Ryan, É J, Boland, M R, McAnena, P F, Lowery, A J, Kerin, M J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504445/
https://www.ncbi.nlm.nih.gov/pubmed/34633438
http://dx.doi.org/10.1093/bjsopen/zrab081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504445/
https://www.ncbi.nlm.nih.gov/pubmed/34633438
http://dx.doi.org/10.1093/bjsopen/zrab081

Ejemplares similares